Gabriele Raffler1, Emanuel Zitt1, Hannelore Sprenger-Mähr1, Mato Nagel2, Karl Lhotta3. 1. Department of Nephrology and Dialysis, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800, Feldkirch, Austria. 2. Laboratory for Molecular Diagnostics, Center for Nephrology and Metabolic Disorders, Weißwasser, Germany. 3. Department of Nephrology and Dialysis, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800, Feldkirch, Austria. Karl.lhotta@lkhf.at.
Abstract
BACKGROUND: Uromodulin (UMOD)-associated kidney disease belongs to the group of autosomal dominant interstitial kidney diseases and is caused by mutations in the UMOD gene. Affected patients present with hyperuricemia, gout, and progressive renal failure. The disease is thought to be very rare but is probably underdiagnosed. METHODS: Two index patients from two families with tubulointerstitial nephropathy and hyperuricemia were examined, including blood and urine chemistry, ultrasound, and mutation analysis of the UMOD gene. In addition, other available family members were studied. RESULTS: In a 46-year-old female patient with a fractional excretion of uric acid of 3 %, analysis of the UMOD gene revealed a p.W202S missense mutation. The same mutation was found in her 72-year-old father, who suffers from gout and end-stage renal disease. The second index patient was a 47-year-old female with chronic kidney disease and gout for more than 10 years. Her fractional uric acid excretion was 3.5 %. Genetic analysis identified a novel p.H250Q UMOD mutation that was also present in her 12-year-old son, who had normal renal function and uric acid levels. CONCLUSION: In patients suffering from chronic tubulointerstitial nephropathy, hyperuricemia, and a low fractional excretion of uric acid mutation, analysis of the UMOD gene should be performed to diagnose UMOD-associated kidney disease.
BACKGROUND:Uromodulin (UMOD)-associated kidney disease belongs to the group of autosomal dominant interstitial kidney diseases and is caused by mutations in the UMOD gene. Affected patients present with hyperuricemia, gout, and progressive renal failure. The disease is thought to be very rare but is probably underdiagnosed. METHODS: Two index patients from two families with tubulointerstitial nephropathy and hyperuricemia were examined, including blood and urine chemistry, ultrasound, and mutation analysis of the UMOD gene. In addition, other available family members were studied. RESULTS: In a 46-year-old female patient with a fractional excretion of uric acid of 3 %, analysis of the UMOD gene revealed a p.W202S missense mutation. The same mutation was found in her 72-year-old father, who suffers from gout and end-stage renal disease. The second index patient was a 47-year-old female with chronic kidney disease and gout for more than 10 years. Her fractional uric acid excretion was 3.5 %. Genetic analysis identified a novel p.H250QUMOD mutation that was also present in her 12-year-old son, who had normal renal function and uric acid levels. CONCLUSION: In patients suffering from chronic tubulointerstitial nephropathy, hyperuricemia, and a low fractional excretion of uric acid mutation, analysis of the UMOD gene should be performed to diagnose UMOD-associated kidney disease.
Authors: Martina Zivná; Helena Hůlková; Marie Matignon; Katerina Hodanová; Petr Vylet'al; Marie Kalbácová; Veronika Baresová; Jakub Sikora; Hana Blazková; Jan Zivný; Robert Ivánek; Viktor Stránecký; Jana Sovová; Kathleen Claes; Evelyne Lerut; Jean-Pierre Fryns; P Suzanne Hart; Thomas C Hart; Jeremy N Adams; Audrey Pawtowski; Maud Clemessy; Jean-Marie Gasc; Marie-Claire Gübler; Corinne Antignac; Milan Elleder; Katja Kapp; Philippe Grimbert; Anthony J Bleyer; Stanislav Kmoch Journal: Am J Hum Genet Date: 2009-08-06 Impact factor: 11.025
Authors: Andrew Kirby; Andreas Gnirke; David B Jaffe; Veronika Barešová; Nathalie Pochet; Brendan Blumenstiel; Chun Ye; Daniel Aird; Christine Stevens; James T Robinson; Moran N Cabili; Irit Gat-Viks; Edward Kelliher; Riza Daza; Matthew DeFelice; Helena Hůlková; Jana Sovová; Petr Vylet'al; Corinne Antignac; Mitchell Guttman; Robert E Handsaker; Danielle Perrin; Scott Steelman; Snaevar Sigurdsson; Steven J Scheinman; Carrie Sougnez; Kristian Cibulskis; Melissa Parkin; Todd Green; Elizabeth Rossin; Michael C Zody; Ramnik J Xavier; Martin R Pollak; Seth L Alper; Kerstin Lindblad-Toh; Stacey Gabriel; P Suzanne Hart; Aviv Regev; Chad Nusbaum; Stanislav Kmoch; Anthony J Bleyer; Eric S Lander; Mark J Daly Journal: Nat Genet Date: 2013-02-10 Impact factor: 38.330
Authors: L B Lopes; C C Abreu; C F Souza; L E R Guimaraes; A A Silva; F Aguiar-Alves; K O Kidd; S Kmoch; A J Bleyer; J R Almeida Journal: Braz J Med Biol Res Date: 2018-03-01 Impact factor: 2.590
Authors: Eric Olinger; Céline Schaeffer; Kendrah Kidd; Elhussein A E Elhassan; Yurong Cheng; Inès Dufour; Guglielmo Schiano; Holly Mabillard; Elena Pasqualetto; Patrick Hofmann; Daniel G Fuster; Andreas D Kistler; Ian J Wilson; Stanislav Kmoch; Laure Raymond; Thomas Robert; Kai-Uwe Eckardt; Anthony J Bleyer; Anna Köttgen; Peter J Conlon; Michael Wiesener; John A Sayer; Luca Rampoldi; Olivier Devuyst Journal: Proc Natl Acad Sci U S A Date: 2022-08-10 Impact factor: 12.779